Singapore markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
28.49-0.05 (-0.16%)
As of 01:37PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 161.67B
Enterprise value 218.45B
Trailing P/E N/A
Forward P/E 12.77
PEG ratio (5-yr expected) 1.03
Price/sales (ttm)2.94
Price/book (mrq)1.75
Enterprise value/revenue 3.98
Enterprise value/EBITDA 29.40

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-28.03%
S&P500 52-week change 328.04%
52-week high 340.37
52-week low 325.20
50-day moving average 327.22
200-day moving average 329.82

Share statistics

Avg vol (3-month) 342.53M
Avg vol (10-day) 336.85M
Shares outstanding 55.67B
Implied shares outstanding 65.67B
Float 85.66B
% held by insiders 10.05%
% held by institutions 168.51%
Shares short (30 Apr 2024) 462.51M
Short ratio (30 Apr 2024) 41.7
Short % of float (30 Apr 2024) 41.10%
Short % of shares outstanding (30 Apr 2024) 41.10%
Shares short (prior month 28 Mar 2024) 465M

Dividends & splits

Forward annual dividend rate 41.68
Forward annual dividend yield 45.89%
Trailing annual dividend rate 31.65
Trailing annual dividend yield 35.78%
5-year average dividend yield 44.02
Payout ratio 4443.24%
Dividend date 314 Jun 2024
Ex-dividend date 409 May 2024
Last split factor 21054:1000
Last split date 317 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.56%
Operating margin (ttm)31.63%

Management effectiveness

Return on assets (ttm)0.93%
Return on equity (ttm)-0.26%

Income statement

Revenue (ttm)54.89B
Revenue per share (ttm)9.72
Quarterly revenue growth (yoy)-19.50%
Gross profit (ttm)N/A
EBITDA 9.62B
Net income avi to common (ttm)-288M
Diluted EPS (ttm)-0.05
Quarterly earnings growth (yoy)-43.80%

Balance sheet

Total cash (mrq)11.93B
Total cash per share (mrq)2.11
Total debt (mrq)69.9B
Total debt/equity (mrq)75.52%
Current ratio (mrq)1.05
Book value per share (mrq)16.28

Cash flow statement

Operating cash flow (ttm)8.58B
Levered free cash flow (ttm)3.46B